A Set of New Tools for Cancer Cell Culturing

With The TumorGenesis solutions and tools, researchers no matter where you are in the world can capture, culture and identify cancer cells, clonal variants and close the gap between in vitro and in vivo.

Tailored Solutions

Are you interested in capturing, culturing, and screening cancer cells and cancer heterogenous colonies.

{Learn More}

Ready-To-Use Systems and Models

View all of our products, tools, and services available for discovery and preclinical testing.

{Learn More}

Already a User?

Already a part of the Tumor Genesis solution? Here you will find Protocols, Publications and FAQ’s, and other helpful tools and hints.

{Learn More}

About Us

TumorGenesis is an innovative biotech company that discovers, develops, partners and licenses in new technologies to advance cancer cell culturing. We are focused on creating the most innovative and the newest cancer cell capturing, culturing, and screening techniques for researchers around the world.

{Learn More}

Our Mission

Providing new tools, solutions and innovative combinations of products and services that will help researchers understand cancer better that will help save patient lives and improve patient outcomes in treatment.

{Learn More}

Our Offers

  • Cancer focused media for true cancer cell culturing
  • Tailored Nanofiber scaffolds as Extra Cellular Matrix
  • Ready to use cancer cell media for cancer cell culturing
  • Generic and ready to use nanofiber scaffolds as ECM for cancer cells
  • Tailored cancer cell screening kits, tools, and services
  • Generic peptide biomarker discovery kits
  • Custom and generic cancer cell libraries

{Learn More}

Ready for a Solution?

Take the first step to your tailored nanofiber scaffold today
by booking a meeting with one of our experts!

“Our goal is to help all of our customers succeed in achieving their goals and objectives in using our products and services, without their success, our number one goal, developing better ways to understand and defeat cancer, all cancers will remain out of our and our customers reach.”

-Richard Gabriel (TumorGenesis)

Our Partners.

Our partners in developing the media for ovarian, breast and leukemia are the following organizations and we are also looking for affiliations and collaborative partners to help commercialize a new way of screening patient samples.